| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/15/2013 | WO2013072763A3 Non-sensitizing transdermal clonidine patch |
| 08/15/2013 | WO2013064703A3 Fkbp subtype-specific rapamycin analogue for use in treatment of diseases |
| 08/15/2013 | WO2013062964A3 Methanol derivatives as trpv3 modulators |
| 08/15/2013 | WO2013042135A8 Heteroaryl compounds as 5-ht4 receptor ligands |
| 08/15/2013 | WO2012098461A8 Fused aminodihydrothiazine derivatives |
| 08/15/2013 | US20130211368 Microfabricated nanopore device for sustained release of therapeutic agent |
| 08/15/2013 | US20130210875 Novel binding site of IKK-beta |
| 08/15/2013 | US20130210849 Methods for treating disorders associated with mGLU receptors including addiction and depression |
| 08/15/2013 | US20130210758 Formulation and method to induce a deep state of relaxation |
| 08/15/2013 | US20130209561 Abuse-resistant opioid dosage form |
| 08/15/2013 | US20130209540 Multi-layer nicotine-containing pharmaceutical composition |
| 08/15/2013 | US20130209441 Process for inhibition of cerebral damage associated with ischemia by anthocyanins and anthocyanidins |
| 08/14/2013 | EP2626352A1 Heterocyclic low-molecular sapp mimetics, a pharmaceutical composition and methods for producing and using same |
| 08/14/2013 | EP2626350A1 Cyclopropane compound |
| 08/14/2013 | EP2626347A1 Dalfampridine polymorph, preparation therefor, and application thereof |
| 08/14/2013 | EP2626073A1 Compound for use in the prevention and/or treatment of a neurogenerative disease or a disease involving an activation of phosphodiesterase-4 (PDE4) |
| 08/14/2013 | EP2625180A2 Porphyrin treatment of neurodegenerative diseases |
| 08/14/2013 | EP2625176A2 Substituted pyridazine carboxamide compounds |
| 08/14/2013 | EP2625169A1 Quinazoline compounds as sodium channel blockers |
| 08/14/2013 | EP2624832A1 Hdac inhibitors to treat charcot-marie-tooth disease |
| 08/14/2013 | EP2624828A1 Picropodophyllin monohydrate or polymorph a in cancer therapy |
| 08/14/2013 | EP2624827A1 Picropodophyllin polymorphs b or c for use in cancer therapy |
| 08/14/2013 | EP2624823A2 Administration of serine protease inhibitors to the stomach |
| 08/14/2013 | EP2624821A1 Combination therapy for the treatment of depression and other non-infectious diseases |
| 08/14/2013 | EP2624816A2 Stimulation of neuroregeneration by flavonoid glycosides |
| 08/14/2013 | EP2624698A1 FURO[3,2-d]PYRIMIDINE COMPOUNDS |
| 08/14/2013 | EP2624697A1 Dihydrobenzoquinazolinone m1 receptor positive allosteric modulators |
| 08/14/2013 | CN103249833A Human monoclonal antibody |
| 08/14/2013 | CN103249733A Fused triazoles for the treatment or prophylaxis of mild cognitive impairment |
| 08/14/2013 | CN103249728A Novel triazole compounds III |
| 08/14/2013 | CN103249726A Acylbenzene derivative |
| 08/14/2013 | CN103249721A Arylamide derivatives as TTX-S blockers |
| 08/14/2013 | CN103249697A Deuterated analogs of pridopidine useful as dopaminergic stabilizers |
| 08/14/2013 | CN103249413A Hydroxylated aminotriazole derivatives as ALX receptor agonists |
| 08/14/2013 | CN103249411A Picropodophyllin monohydrate or polymorph a in cancer therapy |
| 08/14/2013 | CN103249407A Combination therapy for the treatment of depression and other non-infectious diseases |
| 08/14/2013 | CN103242447A Tweak binding antibodies |
| 08/14/2013 | CN103242412A Preparation method of shiny-leaved yellowhorn carpopodium and medical applications |
| 08/14/2013 | CN103242341A Thieno 2,4-substituted pyrimidine compound, and pharmaceutical composition and application thereof |
| 08/14/2013 | CN103242332A 1-N acyl substituted indolone derivative |
| 08/14/2013 | CN103242275A Sesquiterpenoids in zedoary as well as preparation method and application of sesquiterpenoids |
| 08/14/2013 | CN103242219A 2,6-diketone-piperazine (piperidine) type derivative and application thereof |
| 08/14/2013 | CN103242218A N-substituted pipecolic acid derivative, as well as preparation method and application thereof |
| 08/14/2013 | CN103242191A Compound for preventing and treating Alzheimer disease as well as preparation method and application thereof |
| 08/14/2013 | CN103239742A Sachet filler |
| 08/14/2013 | CN103239720A Substance for curing or relieving pain |
| 08/14/2013 | CN103239691A Application of medicine composition in preparation of medicaments for treating headache |
| 08/14/2013 | CN103239687A Rheumatic numbness pain pills |
| 08/14/2013 | CN103239672A Chinese medicine composition for reinforcing qi and nourishing blood, calming nerves and strengthening spleen and nourishing yin and tonifying liver and preparation technology thereof |
| 08/14/2013 | CN103239657A Chinese medicine composition for treating rheumatoid arthritis |
| 08/14/2013 | CN103239640A Traditional Chinese medicine granule for treating infantile convulsion and preparation method thereof |
| 08/14/2013 | CN103239627A Medicament for treating skin disease |
| 08/14/2013 | CN103239625A Traditional Chinese medicinal preparation for treating facial paralysis |
| 08/14/2013 | CN103239607A Chinese medicine preparation for treating amnesia caused by neurasthenia |
| 08/14/2013 | CN103239606A Ginseng composition and application thereof in aspect of adjunctively improving memory |
| 08/14/2013 | CN103239598A Traditional Chinese medicine composition for treatment of Parkinson's disease and application thereof |
| 08/14/2013 | CN103239597A Method for preparing traditional Chinese medicine composition for treatment of parkinson's disease |
| 08/14/2013 | CN103239582A Chinese medicinal preparation for treating migraine |
| 08/14/2013 | CN103239581A Anti-anxiety traditional Chinese medicine composition and preparation method thereof |
| 08/14/2013 | CN103239579A Chinese medicine composition for treating acute facioplegia and preparation method thereof |
| 08/14/2013 | CN103239577A Traditional Chinese medicinal preparation for treating schizophrenia |
| 08/14/2013 | CN103239575A Health-care medicinal wine with functions of supplementing qi, activating blood circulation and lowering blood fat |
| 08/14/2013 | CN103239509A Chinese medicine composition used for tonifying qi and spleen, tonifying kidney and calming heart and preparation method thereof |
| 08/14/2013 | CN103239506A Tongmai oral liquid raw material extract |
| 08/14/2013 | CN103239494A Nasal spray composition for treating migraine and preparation method thereof |
| 08/14/2013 | CN103239452A Brooethyl naltrexone pharmaceutical composition |
| 08/14/2013 | CN103239440A Application of mitiglinide in preparation of medicine for treating cerebral arterial thrombosis |
| 08/14/2013 | CN103239434A Ornithine aspartate composition |
| 08/14/2013 | CN103239407A Solid composition containing iloperidone medicament and preparation method thereof |
| 08/14/2013 | CN103239404A Dual-targeted liposome, and preparation method and application thereof |
| 08/14/2013 | CN103239397A Oxiracetam injection composition and preparation method thereof |
| 08/14/2013 | CN103238835A Health care product for alcoholism dispelling |
| 08/14/2013 | CN102920683B Olanzapine oral instant membrane |
| 08/14/2013 | CN102813816B Traditional Chinese medicine preparation for treating migraine |
| 08/14/2013 | CN102805801B Preparation method of traditional Chinese medicine for treating smoking type insomnia |
| 08/14/2013 | CN102702041B Agomelatine benzenesulfonic acid compound and preparation method thereof |
| 08/14/2013 | CN102631490B Traditional Chinese medicine composition capable of improving immunity and resisting fatigue |
| 08/14/2013 | CN102614135B Cytidine disodium triphosphate suspension powder injection and preparation method thereof |
| 08/14/2013 | CN102397272B Application of butylphthalide and derivatives thereof in preparation of medicines for preventing and treating ALS |
| 08/14/2013 | CN102370724B Hemiplegia treatment ointment for treating cerebrovascular diseases |
| 08/14/2013 | CN102349968B Traditional Chinese medicine for treating insomnia |
| 08/14/2013 | CN102335059B Cooling sleep promoting hat |
| 08/14/2013 | CN102293942B Chinese medicinal composition for treating wry mouth and oblique eyes |
| 08/14/2013 | CN102292094B Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical |
| 08/14/2013 | CN102284016B Body resistance-strengthening and evil-eliminating internal and external therapy traditional Chinese medicine for treating rheumatism of muscles and bones |
| 08/14/2013 | CN102266342B Application of riboflavin tetrabutyrate to preparation of anxiolytic medicament |
| 08/14/2013 | CN102258653B Pinellia ternata and processing method thereof |
| 08/14/2013 | CN102258575B Plaster for treating scapulohumeral periarthritis and its preparation method |
| 08/14/2013 | CN102146137B Antibody to beta-amyloid peptide and application thereof |
| 08/14/2013 | CN102143955B 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
| 08/14/2013 | CN102102114B Preparation of pregabalin and related compounds |
| 08/14/2013 | CN102085197B Venlafaxine slow-release preparation and preparation method thereof |
| 08/14/2013 | CN102007121B 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands |
| 08/14/2013 | CN101955543B Nerve growth factor bound with laminin, and coding gene and application thereof |
| 08/14/2013 | CN101903348B Pyrazole-substituted arylamides |
| 08/14/2013 | CN101838260B Dihydropyrrolones derivative as Caspase-3 inhibitor |
| 08/14/2013 | CN101791406B Use of sphingosine-1-phosphate (S1P) receptor agonists for the treatment of brain degenerative diseases |
| 08/14/2013 | CN101730704B Stable salts of s-adenosylmethionine and process for the preparation thereof |
| 08/14/2013 | CN101664551B Stabilization of hypoxia inducible factor (HIF) alpha |
| 08/14/2013 | CN101316833B Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors |